Metraipolis › archive › dc_d9cb747b61fd

Olanzapine and peripheral metabolic dysregulation: organ-resolved mechanisms, risk, and MASLD-aligned care pathways — Europe PMC PMID:42007333

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42007333
DOI
10.3389/fphar.2025.1729264
License (as archived)
solo-consultazione
Archived
2026-11-03T12:16:03.522Z
SHA-256 of the archived text
e9ec92a3fc8f5249f7e73913c4ed68bd9181229ba9adf68a341e8aa1a45cf7d9
Stable URL of this page
https://metraipolis.com/documento/dc_d9cb747b61fd

How to cite

Olanzapine and peripheral metabolic dysregulation: organ-resolved mechanisms, risk, and MASLD-aligned care pathways — Europe PMC PMID:42007333 — Europe PMC (en), https://europepmc.org/article/MED/42007333 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d9cb747b61fd (Metraipolis archive dc_d9cb747b61fd, sha256 e9ec92a3fc8f5249f7e73913c4ed68bd9181229ba9adf68a341e8aa1a45cf7d9)
BibTeX
@misc{dcd9cb747b61fd,
  title = {Olanzapine and peripheral metabolic dysregulation: organ-resolved mechanisms, risk, and MASLD-aligned care pathways — Europe PMC PMID:42007333},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42007333},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d9cb747b61fd; sha256 e9ec92a3fc8f5249f7e73913c4ed68bd9181229ba9adf68a341e8aa1a45cf7d9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42007333. Agents can read the archived copy with the MCP tool read_document.